The FDA authorized the third monoclonal antibody treatment. Here’s why Vir and GSK say the U.S. still needs COVID-19 therapies
May 27, 2021 at 12:34 PM EDT
There are now three antibody-based treatments available in the U.S. to treat adults and teens with mild or moderate forms of COVID-19, though all require intravenous infusions and are not the kind of medications that can be picked up at a local pharmacy.
